ANUH PHARMA
Back to Balance Sheet
|
ANUH PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-2.08 Cr | ₹-0.42 Cr | ₹-0.77 Cr | ₹0.05 Cr | ₹1.01 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ANUH PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-2.08 Cr |
| Mar2024 | ₹-0.42 Cr |
| Mar2023 | ₹-0.77 Cr |
| Mar2022 | ₹0.05 Cr |
| Mar2021 | ₹1.01 Cr |
How is Deferred Tax Assets / Liabilities of ANUH PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2.08 Cr | Negative | |
| Mar2024 | ₹-0.42 Cr | Negative | |
| Mar2023 | ₹-0.77 Cr | Negative | |
| Mar2022 | ₹0.05 Cr | -95.27 | |
| Mar2021 | ₹1.01 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹776.7 Cr | -5.6% | 5.9% | -6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.6% | 7% | 1.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | 1.6% | 4.6% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,479.0 Cr | 3.1% | 5.9% | 39% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | 1.5% | -2.1% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 0.5% | 9.8% | 5.7% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | -5.6% |
5.9% |
-6% |
| SENSEX | -0.6% |
0.6% |
9.8% |
You may also like the below Video Courses